Business Description
We Can Medicines Co Ltd
ISIN : TW0006929003
Total Employee Number:
1,014Compare
Compare
Traded in other countries / regions
6929.Taiwan IPO Date
2023-06-09Description
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | 4.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.51 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.3 | |||||
3-Year EBITDA Growth Rate | -13.7 | |||||
3-Year FCF Growth Rate | -5.4 | |||||
3-Year Book Growth Rate | 5.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.61 | |||||
9-Day RSI | 34.28 | |||||
14-Day RSI | 39.08 | |||||
3-1 Month Momentum % | -20.34 | |||||
6-1 Month Momentum % | -24.68 | |||||
12-1 Month Momentum % | -30.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.53 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 143.58 | |||||
Days Sales Outstanding | 20.89 | |||||
Days Payable | 84.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | 5.81 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.15 | |||||
Operating Margin % | -2.1 | |||||
Net Margin % | -2.27 | |||||
EBITDA Margin % | 8.48 | |||||
FCF Margin % | 6.33 | |||||
OCF Margin % | 7.45 | |||||
ROE % | -6.72 | |||||
ROA % | -2.41 | |||||
ROIC % | -3.17 | |||||
3-Year ROIIC % | -49.49 | |||||
ROC (Joel Greenblatt) % | -2.39 | |||||
ROCE % | -2.24 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 80.71 | |||||
PS Ratio | 0.31 | |||||
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 0.96 | |||||
Price-to-Free-Cash-Flow | 4.91 | |||||
Price-to-Operating-Cash-Flow | 4.17 | |||||
EV-to-EBIT | -40.38 | |||||
EV-to-EBITDA | 7.03 | |||||
EV-to-Revenue | 0.6 | |||||
EV-to-FCF | 9.44 | |||||
Price-to-GF-Value | 0.55 | |||||
Earnings Yield (Greenblatt) % | -2.48 | |||||
FCF Yield % | 20.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
We Can Medicines Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 3,221.803 | ||
| EPS (TTM) (NT$) | -1.63 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -2.01 | ||
| 3-Year Sortino Ratio | -1.98 | ||
| Volatility % | 36.28 | ||
| 14-Day RSI | 39.08 | ||
| 14-Day ATR (NT$) | 0.948634 | ||
| 20-Day SMA (NT$) | 23.3975 | ||
| 12-1 Month Momentum % | -30.06 | ||
| 52-Week Range (NT$) | 21.05 - 36.5 | ||
| Shares Outstanding (Mil) | 45.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
We Can Medicines Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
We Can Medicines Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.271000 Cash Dividend | 2024-08-01 | 65.80 (+1.08%) |
Show
Entries
We Can Medicines Co Ltd Frequently Asked Questions
What is We Can Medicines Co Ltd(ROCO:6929)'s stock price today?
The current price of ROCO:6929 is NT$22.30. The 52 week high of ROCO:6929 is NT$36.50 and 52 week low is NT$21.05.
When is next earnings date of We Can Medicines Co Ltd(ROCO:6929)?
The next earnings date of We Can Medicines Co Ltd(ROCO:6929) is .
Does We Can Medicines Co Ltd(ROCO:6929) pay dividends? If so, how much?
We Can Medicines Co Ltd(ROCO:6929) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on We Can Medicines Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers